Norwood Receives TGA for Laser Vision Correction Technology
Richard Walmsley, Chief Executive Officer of Norwood Devices, a division of
medical technologies group Norwood Abbey, announced the company had received
Therapeutic Goods Administration (TGA) approval for its Centurion SES Epikeratome
the key component of Epi-LASIK technology, the next generation of vision
correction surgery. TGA approval in Australia follows FDA and European CE Mark
approvals in 2004.